Stock Comparison

ARGX vs DNTH

argenx NV ADR and Dianthus Therapeutics Inc. side by side — valuation, profitability, growth and risk.

ARGX

argenx NV ADR

Healthcare

DNTH

Dianthus Therapeutics Inc.

Healthcare

Valuation

Market Cap

$53.23B

$5.84B

P/E (TTM)

32.7

—

Forward P/E

30.4

—

Price/Sales

10.0

3,065.7

Price/Book

6.4

5.1

EV/EBITDA

27.6

-7.2

Dividend Yield

—

Profitability

Net Margin

30.44%

-847.53%

Operating Margin

27.34%

-14318.04%

Return on Equity

23.60%

-26.10%

Return on Assets

11.60%

-17.70%

Growth (YoY)

Revenue Growth

59.30%

294.30%

Earnings Growth

95.20%

0.00%

Price & Risk

Beta

-0.0

0.1

52-Week High

$939.68

$112.64

52-Week Low

$652.43

$20.25

Analyst Target

$1,085.78

$137.62

Compare ARGX and DNTH your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.